KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogenomics (NEO) Other Operating Expenses (2016 - 2026)

Neogenomics filings provide 17 years of Other Operating Expenses readings, the most recent being $23.8 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 5.06% to $23.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $120.9 million, a 32.32% increase, with the full-year FY2025 number at $119.8 million, up 41.47% from a year prior.
  • Other Operating Expenses hit $23.8 million in Q1 2026 for Neogenomics, down from $24.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $44.1 million in Q2 2025 to a low of $16.3 million in Q1 2023.
  • Median Other Operating Expenses over the past 5 years was $20.2 million (2024), compared with a mean of $21.8 million.
  • Biggest five-year swings in Other Operating Expenses: dropped 0.89% in 2022 and later skyrocketed 89.98% in 2025.
  • Neogenomics' Other Operating Expenses stood at $17.1 million in 2022, then increased by 5.43% to $18.1 million in 2023, then soared by 33.06% to $24.0 million in 2024, then increased by 0.1% to $24.1 million in 2025, then decreased by 0.99% to $23.8 million in 2026.
  • The last three reported values for Other Operating Expenses were $23.8 million (Q1 2026), $24.1 million (Q4 2025), and $28.9 million (Q3 2025) per Business Quant data.